BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20888350)

  • 1. Angioarchitectural morphometrics of brain tumors: are there any potential histopathological biomarkers?
    Di Ieva A
    Microvasc Res; 2010 Dec; 80(3):522-33. PubMed ID: 20888350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractal analysis of microvascular networks in malignant brain tumors.
    Di Ieva A
    Clin Neuropathol; 2012; 31(5):342-51. PubMed ID: 22939175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angioarchitectural heterogeneity in human glioblastoma multiforme: a fractal-based histopathological assessment.
    Di Ieva A; Grizzi F; Sherif C; Matula C; Tschabitscher M
    Microvasc Res; 2011 Mar; 81(2):222-30. PubMed ID: 21192955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational Fractal-Based Analysis of Brain Tumor Microvascular Networks.
    Di Ieva A; Al-Kadi OS
    Adv Neurobiol; 2024; 36():525-544. PubMed ID: 38468051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of microvascular fractal dimension with positron emission tomography [(11)C]-methionine uptake in glioblastoma multiforme: preliminary findings.
    Di Ieva A; Grizzi F; Tschabitscher M; Colombo P; Casali M; Simonelli M; Widhalm G; Muzzio PC; Matula C; Chiti A; Rodriguez y Baena R
    Microvasc Res; 2010 Sep; 80(2):267-73. PubMed ID: 20394759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The microvascular network of the pituitary gland: a model for the application of fractal geometry to the analysis of angioarchitecture and angiogenesis of brain tumors.
    Di Ieva A; Grizzi F; Ceva-Grimaldi G; Aimar E; Serra S; Pisano P; Lorenzetti M; Tancioni F; Gaetani P; Crotti F; Tschabitscher M; Matula C; Rodriguez Y Baena R
    J Neurosurg Sci; 2010 Jun; 54(2):49-54. PubMed ID: 21313955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancer.
    Langenkamp E; Molema G
    Cell Tissue Res; 2009 Jan; 335(1):205-22. PubMed ID: 18677515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for angiogenesis and antiangiogenic drugs in clinical oncology.
    Bertolini F
    Breast; 2009 Oct; 18 Suppl 3():S48-50. PubMed ID: 19914542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Algorithm for the standardized assessment of vascular patterns in glioblastoma specimens.
    Preusser M; Birner P; Hainfellner JA
    Clin Neuropathol; 2004; 23(5):238-40. PubMed ID: 15581027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
    Shibuya M
    FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvascular morphometrics of the hypophysis and pituitary tumors: from bench to operating theatre.
    Di Ieva A; Weckman A; Di Michele J; Rotondo F; Grizzi F; Kovacs K; Cusimano MD
    Microvasc Res; 2013 Sep; 89():7-14. PubMed ID: 23651686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress and challenges in the identification of biomarkers for EGFR and VEGFR targeting anticancer agents.
    Le Tourneau C; Vidal L; Siu LL
    Drug Resist Updat; 2008 Jun; 11(3):99-109. PubMed ID: 18515176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of chemokine CXCL12 in embryonic and brain tumor angiogenesis.
    Li M; Ransohoff RM
    Semin Cancer Biol; 2009 Apr; 19(2):111-5. PubMed ID: 19038344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: a longitudinal in vivo and ex vivo study.
    Valable S; Lemasson B; Farion R; Beaumont M; Segebarth C; Remy C; Barbier EL
    NMR Biomed; 2008 Nov; 21(10):1043-56. PubMed ID: 18615861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor vessel biology in pediatric intracranial ependymoma.
    Wagemakers M; Sie M; Hoving EW; Molema G; de Bont ES; den Dunnen WF
    J Neurosurg Pediatr; 2010 Apr; 5(4):335-41. PubMed ID: 20367336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Angiogenesis in brain neoplasms--biological and clinical aspects].
    Wojtukiewicz MZ; Matuszewska EA; Zimnoch L
    Postepy Hig Med Dosw; 1998; 52(6):577-90. PubMed ID: 10093477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional reconstruction of tumor microvasculature: simultaneous visualization of multiple components in paraffin-embedded tissue.
    Gijtenbeek JM; Wesseling P; Maass C; Burgers L; van der Laak JA
    Angiogenesis; 2005; 8(4):297-305. PubMed ID: 16328157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling the effects of vasculature evolution on early brain tumor growth.
    Gevertz JL; Torquato S
    J Theor Biol; 2006 Dec; 243(4):517-31. PubMed ID: 16938311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and cellular biomarkers for angiogenesis in clinical oncology.
    Bertolini F; Mancuso P; Shaked Y; Kerbel RS
    Drug Discov Today; 2007 Oct; 12(19-20):806-12. PubMed ID: 17933680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.